AERI Forecast and Technical Stock Analysis
Buy candidate since 2019-09-20 PDF
Aerie Pharmaceuticals gained 1.83% in the last trading day ( Friday, 20th Sep 2019 ), rising from $22.91 to $23.33 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.90% from a day low at $22.22 to a day high of $23.53. The price has risen in 6 of the last 10 days and is up by 23.96% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.53 million more shares were traded than the day before. In total, 1.37 million shares bought and sold for approximately $31.91 million.
- 30 day high of the AERI stock price was $24.61 and low was $18.02.
- 90 day high was $31.53 and low was $18.02.
- 52 week high for Aerie Pharmaceuticals - $63.20 and low - $18.02.
Aerie Pharmaceuticals lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $23.42 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.97% during the next 3 months and, with 90% probability hold a price between $13.47 and $18.28 at the end of this period.
Only positive signals in the chart today. Aerie Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $22.82 and $22.35. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday September 18, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 56 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aerie Pharmaceuticals finds support from accumulated volume at $22.92.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.31 between high and low, or 5.90%. For the last week, the stock has had a daily average volatility of 7.35%.
Our recommended stop-loss: $22.21 (-4.79%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)
7.35 %Average volatility
Very Low Low Medium High Very High
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.
|AERI $23.33 ($0.42 1.83%)|
AERI is up $0.42 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AERI based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AERI analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!